Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
The Series H-1 warrants and Series H-2 warrants will have an exercise price of $4.55 per share of common stock and will be exercisable immediately upon issuance.
- The Series H-1 warrants and Series H-2 warrants will have an exercise price of $4.55 per share of common stock and will be exercisable immediately upon issuance.
- Ladenburg Thalmann & Co. Inc. is acting as the exclusive placement agent for the private placement.
- The closing of the private placement is expected to occur on or about March 12, 2024, subject to the satisfaction of customary closing conditions.
- The Company intends to use the net proceeds from the private placement for working capital and for general corporate purposes.